Oscar Health, Inc. (OSCR) Balance Sheet
OSCR balance sheet, 2025
December 31, 2025 · U.S. dollars$6.33B assets = $5.34B liabilities + $980.7M equity
Both columns are drawn to the same scale: what OSCR owns equals what it owes plus shareholders’ equity. Hover a block for its value.
OSCR financial health
Descriptive bands, not a rating. Fiscal 2025.
OSCR balance sheet trends, 2019–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1.35B2019 | $6.33B2025 | +29.4%/yr | |
| Total liabilities | $494.2M2019 | $5.34B2025 | +48.7%/yr | |
| Shareholders’ equity | $852.7M2019 | $977.6M2025 | +2.3%/yr | |
| Cash & short-term investments | $670.4M2019 | $3.99B2025 | +34.6%/yr | |
| Total debt | $142.5M2020 | $430.1M2025 | +24.7%/yr | |
| Net cash (debt) | $1.05B2020 | $3.56B2025 | +$2.5B | |
| Working capital | $231.4M2019 | −$249.2M2025 | −$480.5M | |
| Book value per share | $7.752021 | $3.732025 | −16.7%/yr | |
| Current ratio | 1.472019 | 0.952025 | −0.52 | |
| Debt / equity | 0.212021 | 0.442025 | +0.23 | |
| Shares outstanding | 179.0M2021 | 262.4M2025 | +10.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
OSCR assets
OSCR liabilities and equity
OSCR debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
OSCR balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & short-term investments | $3.99B | $2.15B | $2.56B | $2.96B | $1.69B | $1.19B | $670.4M |
| Cash & equivalents | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B | $826.3M | $336.6M |
| Short-term investments | $1.22B | $624.5M | $689.8M | $1.40B | $587.1M | $366.4M | $333.8M |
| Receivables | $442.6M | $315.9M | $494.4M | $1.16B | $1.04B | $96.5M | $55.2M |
| Inventory | $0 | $0 | −$3.05B | −$1.16B | −$614.8M | −$1.29B | −$727.0M |
| Other current assets | $180.1M | $377.6M | $2.07B | $1.19B | $642.9M | $1.29B | $727.0M |
| Total current assets | $4.61B | $2.85B | $2.07B | $4.14B | $2.76B | $1.29B | $725.6M |
| Property, plant & equipment (net) | $88.3M | $66.8M | $61.9M | $59.9M | $46.6M | $35.8M | $33.1M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $179.1M | $96.5M | $55.2M |
| Long-term investments | $1.22B | $624.5M | $689.8M | $1.40B | $587.1M | $366.4M | $333.8M |
| Other non-current assets | $407.2M | $1.30B | $778.1M | $0 | $0 | $484.2M | $199.3M |
| Total assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B | $1.35B |
| Liabilities | |||||||
| Accounts payable | −$99.8M | $1.40B | $1.03B | $1.37B | $718.8M | $480.8M | $494.2M |
| Deferred revenue | — | — | — | $79.0M | $75.0M | — | — |
| Total current liabilities | $4.86B | $3.17B | −$175.3M | $2.97B | $1.62B | $480.8M | $494.2M |
| Long-term debt | $430.1M | $299.6M | $298.8M | $298.0M | $0 | $142.5M | $0 |
| Other long-term liabilities | $52.0M | $61.3M | $2.67B | $370.1M | $315.7M | $0 | $14.5M |
| Total liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B | $3.57B | $494.2M |
| Shareholders' equity | |||||||
| Common stock & paid-in capital | $3,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 |
| Retained earnings (deficit) | −$3.29B | −$2.85B | −$2.88B | −$2.61B | −$2.00B | −$1.43B | −$1.01B |
| Treasury stock | — | — | — | −$2.9M | −$2.9M | — | — |
| Accumulated other comprehensive income | $18.0M | −$1.8M | $1.3M | −$9.7M | −$3.7M | $879,000 | −$27,000 |
| Minority interest | $3.1M | $2.8M | $2.1M | $2.0M | $5.3M | — | — |
| Total shareholders' equity | $977.6M | $1.01B | $804.0M | $890.4M | $1.39B | −$1.30B | $852.7M |
| Key figures | |||||||
| Total debt | $430.1M | $299.6M | $298.8M | $298.0M | $297.4M | $142.5M | — |
| Net cash (debt) | $3.56B | $1.85B | $2.26B | $2.66B | $1.39B | $1.05B | — |
| Working capital | −$249.2M | −$326.5M | $2.25B | $1.18B | $1.14B | $808.4M | $231.4M |
| Tangible book value | $977.6M | $1.01B | $804.0M | $890.4M | $1.21B | −$1.39B | $797.5M |
| Book value per share | $3.73 | $3.81 | $3.63 | $4.19 | $7.75 | — | — |
| Shares outstanding | 262.4M | 265.9M | 221.7M | 212.5M | 179.0M | — | — |
| Current ratio | 0.95 | 0.90 | — | 1.40 | 1.71 | 2.68 | 1.47 |
| Quick ratio | 0.91 | 0.78 | — | 1.39 | 1.69 | 2.68 | 1.47 |
| Debt / equity | 0.44 | 0.30 | 0.37 | 0.33 | 0.21 | — | — |
| Equity / assets | 15.5% | 20.9% | 22.3% | 19.7% | 41.8% | −57.0% | 63.3% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $8.56B | $6.80B | $3.99B | $3.04B | $3.54B | $2.99B | $2.15B | $1.71B | $2.63B | $2.23B | $2.56B | $2.44B |
| Cash & equivalents | $4.08B | $4.81B | $2.77B | $2.15B | $2.60B | $2.24B | $1.53B | $1.21B | $2.27B | $2.23B | $1.87B | $1.40B |
| Short-term investments | $4.48B | $1.99B | $1.22B | $887.6M | $938.1M | $751.5M | $624.5M | $503.8M | $363.6M | $616.1M | $689.8M | $1.04B |
| Receivables | $380.1M | $587.0M | $598.5M | $697.5M | $745.7M | $763.4M | $315.9M | $300.6M | $711.8M | $342.9M | $494.4M | $539.0M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$2.67B | −$656.9M | −$3.05B | −$331.9M |
| Other current assets | $437.6M | $390.5M | $33.0M | $27.9M | $30.5M | $23.0M | $377.6M | $357.5M | $1.99B | $656.9M | $2.07B | $340.3M |
| Total current assets | $9.37B | $7.78B | $4.62B | $3.76B | $4.31B | $3.77B | $2.85B | $2.37B | $2.67B | $2.57B | $2.07B | $2.99B |
| Property, plant & equipment (net) | $101.5M | $94.2M | $88.3M | $83.4M | $77.7M | $72.0M | $66.8M | $66.6M | $64.0M | $61.4M | $61.9M | $62.0M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $4.48B | $1.99B | $1.22B | $887.6M | $938.1M | $751.5M | $624.5M | $503.8M | $363.6M | $616.1M | $689.8M | $1.04B |
| Other non-current assets | $0 | $0 | $398.6M | $1.01B | $1.06B | $1.25B | $1.30B | $1.54B | $1.91B | $1.17B | $778.1M | $0 |
| Total assets | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | $3.60B | $3.35B |
| Liabilities | ||||||||||||
| Accounts payable | −$196.5M | −$142.5M | $1.46B | $1.57B | $1.57B | $1.49B | $1.40B | $1.41B | $1.31B | −$242.9M | $1.03B | $260.1M |
| Deferred revenue | — | — | $166.2M | $77.1M | — | — | — | — | — | $65.5M | — | $71.6M |
| Total current liabilities | $8.69B | $7.14B | $4.21B | $3.42B | $4.87B | $4.15B | $3.46B | $2.95B | −$181.3M | −$177.4M | −$175.3M | $2.06B |
| Long-term debt | $431.6M | $430.9M | $430.1M | $686.3M | $299.9M | $299.7M | $299.6M | $299.4M | $299.2M | $299.0M | $298.8M | $298.6M |
| Other long-term liabilities | $50.5M | $51.4M | $701.7M | $612.5M | $57.3M | $59.3M | $61.3M | $63.5M | $3.75B | $3.26B | $2.67B | $68.6M |
| Total liabilities | $9.17B | $7.62B | $5.34B | $4.72B | $5.22B | $4.51B | $3.82B | $3.32B | $3.87B | $3.38B | $2.80B | $2.43B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $3,000 | $3,000 | $3,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 |
| Retained earnings (deficit) | −$2.25B | −$2.62B | −$3.29B | −$2.94B | −$2.80B | −$2.58B | −$2.85B | −$2.70B | −$2.64B | −$2.70B | −$2.88B | −$2.73B |
| Accumulated other comprehensive income | −$8.2M | $5.0M | $18.0M | $16.4M | $13.7M | $9.6M | −$1.8M | $26.1M | −$2.6M | −$2.6M | $1.3M | −$4.5M |
| Minority interest | $3.1M | $3.1M | $3.1M | $2.9M | $2.9M | — | — | — | — | — | — | — |
| Total shareholders' equity | $2.05B | $1.66B | $977.6M | $1.02B | $1.16B | $1.33B | $1.01B | $1.16B | $1.14B | $1.03B | $804.0M | $919.5M |
| Key figures | ||||||||||||
| Total debt | $431.6M | $430.9M | $430.1M | $686.3M | $299.9M | $299.7M | $299.6M | $299.4M | $299.2M | $299.0M | $298.8M | $298.6M |
| Net cash (debt) | $8.12B | $6.37B | $3.56B | $2.35B | $3.24B | $2.69B | $1.85B | $1.41B | $2.33B | $1.93B | $2.26B | $2.15B |
| Working capital | $683.7M | $637.0M | $409.2M | $341.8M | −$552.3M | −$374.1M | −$618.1M | −$586.7M | $2.85B | $2.75B | $2.25B | $930.7M |
| Tangible book value | $2.05B | $1.66B | $977.6M | $1.02B | $1.16B | $1.33B | $1.01B | $1.16B | $1.14B | $1.03B | $804.0M | $919.5M |
| Book value per share | $6.15 | $5.05 | $3.45 | $3.95 | $4.29 | $4.36 | $3.81 | $4.78 | $3.74 | $3.51 | $3.54 | $4.12 |
| Shares outstanding | 333.4M | 329.8M | 283.2M | 259.3M | 270.2M | 305.9M | 265.9M | 243.1M | 304.0M | 293.8M | 227.1M | 223.1M |
| Current ratio | 1.08 | 1.09 | 1.10 | 1.10 | 0.89 | 0.91 | 0.82 | 0.80 | — | — | — | 1.45 |
| Quick ratio | 1.03 | 1.03 | 1.09 | 1.09 | 0.88 | 0.90 | 0.71 | 0.68 | — | — | — | 1.45 |
| Debt / equity | 0.21 | 0.26 | 0.44 | 0.67 | 0.26 | 0.22 | 0.30 | 0.26 | 0.26 | 0.29 | 0.37 | 0.32 |
| Equity / assets | 18.3% | 17.9% | 15.5% | 17.8% | 18.1% | 22.8% | 20.9% | 25.9% | 22.7% | 23.4% | 22.3% | 27.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 13, 2026); data from EODHD.
OSCR financial position
At the end of fiscal 2025 (December 31, 2025), Oscar Health had total assets of $6.3 billion (up 30.7% from a year earlier), total liabilities of $5.3 billion and shareholders' equity of $977.6 million. It held $4.0 billion in cash and short-term investments against $430.1 million of debt, a net cash position of $3.6 billion. Its current ratio was 0.95. In the latest quarter (ended June 30, 2026) total assets were $11.2 billion and equity $2.1 billion.
Related: OSCR income statement, OSCR cash flow statement, OSCR key metrics. See the OSCR stock overview for the latest quote and news.
OSCR balance sheet FAQ
What are Oscar Health's total assets?
Oscar Health reported total assets of $6.3 billion at the end of fiscal 2025 (December 31, 2025), compared with $4.8 billion a year earlier.
How much debt does Oscar Health have?
Oscar Health had $430.1 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.44.
How much cash does Oscar Health have?
Oscar Health held $4.0 billion in cash and short-term investments at the end of fiscal 2025; with $430.1 million of debt that is net cash of $3.6 billion.
What is Oscar Health's book value?
Oscar Health's shareholders' equity (book value) was $977.6 million at the end of fiscal 2025, or $3.73 per share.
What is Oscar Health's current ratio?
Oscar Health had current assets of $4.6 billion and current liabilities of $4.9 billion, a current ratio of 0.95 (current liabilities exceed current assets).